Trial · NCT04534673
Pegylated Interferon Lambda for Treatment of COVID-19 Infection
NCT04534673, Phase 2, Completed, Soroka University Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pegylated Interferon Lambda for Treatment of COVID-19 Infection. Trials, record NCT04534673. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04534673
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pegylated Interferon Lambda for Treatment of COVID-19 Infection
- NCT number
- NCT04534673
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 9 participants, actual
- Lead sponsor
- Soroka University Medical Center
- Conditions
- COVID-19
- Interventions
- Lambda 180 mcg S.C
- First posted
- 2020-09-01
- Last updated
- 2026-04-30
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Viral shedding in days since initial diagnosis | 21 days | The duration of viral shedding in days since initial diagnosis, as determined by RT-PCR to COVID-19. |
| Primary | Rate of adverse events and severe adverse events | 21 days from entry | Rate of treatment-emergent and treatment-related severe adverse events (SAEs) |
| Secondary | Time to clinical recovery | 72 Hours | the time (in hours) from initiation of trial treatment (Lambda or standard care) until normalization of fever, respiratory rate, and oxygen saturation, and alleviation of cough, sustained for at least 72 hours. |
| Secondary | Rate of non-invasive or mechanical ventilation | 28 Days | Requirement for non-invasive (bipap) or mechanical ventilation |
| Secondary | Length of hospital stay | 28 Days | length of hospital stay from admission to discharge |
| Secondary | All-cause mortality | At day 28 following admission to the hospital | All-cause mortality |
| Secondary | Undetectable COVID-19 virus levels | At days 7,14 and 21 from admission | Rate of undetectable COVID-19 virus levels at different days |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04534673
GET https://conductscience.org/api/trials/v1/NCT04534673/registered